FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:1816-1817 December 9, 1993 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Angell, M.

To the Editor: In her editorial (July 22 issue),¹ Dr. Angell charges that women have been discriminated against in three key areas; yet, my observations and the evidence she presents do not support the charges.

First, Dr. Angell notes, "diseases that affect [women] disproportionately are less likely to be studied." In the area I am most familiar with -- oncology -- this assertion is ludicrous. In 1993 the National Cancer Institute budgeted $273 million for research on cancers specific to women, including breast, cervical, ovarian, and uterine cancers, and $41 million for research on cancers specific to men, including prostate . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.